XML 9 R2.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2021
Mar. 31, 2021
Current assets    
Cash and cash equivalents $ 1,775,673 $ 982,538
Other receivables and prepayments 1,360,967 5,506,203
Short-term investments 2,137,315 5,073,548
Short-term investments – related party 6,611,040 3,966,476
Total current assets 11,884,995 15,528,765
Non-current assets    
Property, plant and equipment, net 301,760 48,292
Right of use assets 433,253 49,104
Other assets 35,152 6,645
TOTAL ASSETS 12,655,160 15,632,806
Current liabilities    
Accounts payable 6,737 22,144
Taxes payable 2,010,867 1,972,043
Accrued liabilities and other current liabilities 744,949 334,996
Related party payable 547,382 688,371
Right of use liabilities 131,479 29,739
Convertible notes, net 4,023,312
Total current liabilities 3,441,414 7,070,605
Right of use liabilities – non-current portion 257,886 9,913
TOTAL LIABILITIES 3,699,300 7,080,518
COMMITMENTS & CONTINGENCIES
Stockholders’ Equity    
Ordinary Shares, $0.0001 par value, 500,000,000 shares authorized; 19,308,371 and 13,263,066 shares issued and outstanding as of September 30, 2021 and March 31, 2021, respectively 1,931 1,326
Additional paid-in capital 22,472,407 14,845,829
Share to be issued 19 195,600
Statutory reserves 589,659 589,659
Accumulated deficit (13,296,687) (5,901,107)
Accumulated other comprehensive income (231,801) (567,333)
Total Stockholders’ equity 9,535,528 9,163,974
Non-controlling interest (579,668) (611,686)
TOTAL EQUITY 8,955,860 8,552,288
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 12,655,160 $ 15,632,806